Avene Thermal Spring Water: an active component with specific properties

被引:41
作者
Merial-Kieny, C. [1 ]
Castex-Rizzi, N. [2 ]
Selas, B. [3 ]
Mery, S. [1 ]
Guerrero, D.
机构
[1] Labs Dermatol Avene, Lavaur, France
[2] Pierre Fabre Dermocosmet, Lab Pharmacol Cellulaire, Toulouse, France
[3] Lab Eau, Avene, France
关键词
anti-inflammatory; atopic dermatitis; antiradical; Avene Thermal Spring Water; dermatology; hydrotherapy; ATOPIC-DERMATITIS PATIENTS; HYDROTHERAPY; INFLAMMATION; LIPIDS;
D O I
10.1111/j.1468-3083.2010.03892.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Avene Thermal Spring Water (TSW) is a natural active component characterized by a low mineral content. In vitro experiments have demonstrated the effect of Avene TSW on membrane fluidity, its antiradical and anti-inflammatory properties, its effects on many mediators involved in the immune response and its stimulating effect on keratinocyte differentiation. The clinical efficacy of the water was demonstrated at the hydrotherapy centre in chronic and disabling diseases such as atopic dermatitis but also in various settings in medical and post dermatology procedure such as photodynamic therapy or photothermolysis. All these data support the fact that the Avene TSW is an active component.
引用
收藏
页码:2 / 5
页数:4
相关论文
共 22 条
[1]  
Alirezai M, 2000, EUR J DERMATOL, V10, P370
[2]   Sensory analysis of four medical spa spring waters containing various mineral concentrations [J].
Bacle, I ;
Meges, S ;
Lauze, C ;
Macleod, P ;
Dupuy, P .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1999, 38 (10) :784-786
[3]   Beneficial effects of spraying low mineral content thermal spring water after fractional photothermolysis in patients with dermal melasma [J].
Barolet, D. ;
Lussier, I. ;
Mery, S. ;
Merial-Kieny, C. .
JOURNAL OF COSMETIC DERMATOLOGY, 2009, 8 (02) :114-118
[4]  
Boisnic S, 2001, INT J TISSUE REACT, V23, P89
[5]   Molecular characterization of inflammation and Staphylococcus aureus colonization of involved skin of atopic dermatitis patients [J].
Casas, C. ;
Ginisty, H. ;
Alvarez-Georges, S. ;
Viode, C. ;
Lejeune, O. ;
Rouvrais, C. ;
Schmitt, A. M. ;
Redoules, D. .
SKIN PHARMACOLOGY AND PHYSIOLOGY, 2008, 21 (05) :260-268
[6]  
CEZANNE L, 1993, SKIN PHARMACOL, V6, P231
[7]  
CHARVERON M, 2002, WORLD C DERM PAR
[8]  
Dechelette C, 2007, WORLD C DERM BUEN AI
[9]  
Garcia Barbara D, 2007, J Drugs Dermatol, V6, P924
[10]  
Giannetti A, 2005, ANN DERMATOL VENER, V132, p6S12